COL4A3 and cystic kidney disease: Furthermore, the 2024 guidelines on behalf of ERKNet, ERA, and ESPN, focusing on disorders resulting from genetic defects in the COL4A3/4/5 genes (Alport syndrome spectrum disorders), explicitly include cystic kidney disease as a criterion for which genetic testing for these genes should be performed.